We are monitoring the impact of COVID-19 on North America High Throughput Screening Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6288
Share on
Share on

North America High Throughput Screening Market Research Report - Segmented By Product, By Technology, By Application, By End User & By Country(US, Canada and Rest of North America) -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 6288
Pages: 145

North America High Throughput Screening Market Size (2020 to 2025)

The size of the High Throughput Screening Market in North America was worth USD 6.16 billion in 2020 and predicted to grow USD 8.69 billion by 2025. This market is forecasted to grow at a CAGR of 7.12% from 2020 to 2025.

Factors such as advancements in a high number of assay kits and reagents used in top throughput screening techniques, the evolution of preclinical drug development and discovery systems, through the adoption of human stem cell-based high throughput screenings and assays are majorly driving the North American HTS market. Advancements of technologies leading to the emergence of innovative technologies and platforms like analytical tools that deal with massive amounts of data are further significantly expanding the market. Rise in demand for high throughput screening devices in stem cell research for the assessment of excretion, metabolism, distribution, and absorption characteristics and investigation of functional activity are further lavishing the growth rate of the North America High Throughput Screening Market.

Also, availability of government funding, increasing demand and a growing number in applications of high throughput screening devices in the pharmacy industry, adoption of high throughput screening devices in production and research fields, rise in outsourced drug discovery services, collaborations of research and academic institutions with pharmaceutical industries for developing innovative ways for drug delivery are further catalyzing the growth of the North American high throughput screening market.

Certain restraints are challenging the growth of North America's high throughput screening market. They are high costs, restrictions in budgets of academic institutions due to which they find difficulties in affording expensive instruments that are essential for research purposes. High Maintenance costs, other indirect expenses are likely to hinder the high throughput screening market during the forecast period.

This research report segmented and sub-segmented into the following categories:

  • By Product: Consumables and Reagents, Instruments, Software and Services
  • By Technology: Cell-based Assays, Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, and Bioinformatics
  • By Application: Target Identification, Primary Screening, Toxicology, and Others
  • By End User: Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organizations and Other End Users
  • By Country: The United States, Canada and Rest of North America

Regionally, North America held the largest share in the global market, followed by Europe, and the Asia Pacific. Growth in the developed regions such as North America is primarily driven by the massive spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and the presence of major companies in this region.

The advances in combinatorial chemistry and the field of genomics are responsible for the significant growth of the U.S. high throughput screening market. Also, huge investments by the biotechnology and pharmaceutical industry in terms of miniaturization, automation, and assay methodology for high throughput screening will further help in the growth of the North American market. The availability of government funding and the drug discovery techniques using 3D-cell cultures have increased popularity among companies competing to reach the market with a new drug molecule. According to the American Cancer Society, over 1.7 million cases are cancer patients, about 606,880 Americans die in a single year. SPARC Drug discovery in Canada starts researching on functional human proteomics, and a high throughput screening facility to provide scientists access to equipment resources such as automation and liquid handling robotics, high content imaging and high throughput functional screens, and it is funded by Canada Foundation for Innovation (CFI).

Companies playing a dominant role in the North America High Throughput Screening Market profiled in this report are Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Consumables and Reagents                                            

                                5.1.3 Instruments                                           

                                5.1.4 Software and Services                                       

                                5.1.5  Y-o-Y Growth Analysis, By Product                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                            

                                5.1.7  Market Share Analysis, By Product                                              

                5.2 Technology                                                 

                                5.2.1 Introduction                                           

                                5.2.2 Cell-based Assays                                                

                                                5.2.2.1 2D Cell Culture                   

                                                5.2.2.2 3D Cell Culture                   

                                                                5.2.2.2.1 Scaffold-Based Technology      

                                                                                5.2.2.2.1.1 Hydrogels

                                                                                5.2.2.2.1.2 Inert Matrix/Solid Scaffolds

                                                                5.2.2.2.2 Scaffold-Free Technology         

                                                                                5.2.2.2.2.1 Microplates

                                                                                5.2.2.2.2.2 Hanging-Drop Plates

                                                                                5.2.2.2.2.3 Ultra-Low Binding Plates

                                                                                5.2.2.2.2.4 Other Scaffold-Free Technologies

                                                5.2.2.3 Perfusion Cell Culture                     

                                5.2.3 Lab-on-a-chip                                        

                                5.2.4 Ultra-High-Throughput Screening                                 

                                5.2.5 Label-Free Technology                                      

                                5.2.6 Bioinformatics                                       

                                5.2.7 Y-o-Y Growth Analysis, By Technology                                        

                                5.2.8 Market Attractiveness Analysis, By Technology                                      

                                5.2.9 Market Share Analysis, By Technology                                        

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Target Identification                                           

                                5.3.3 Primary Screening                                

                                5.3.4 Toxicology                                               

                                5.3.5 Others                                      

                                5.3.6 Y-o-Y Growth Analysis, By Application                                         

                                5.3.7 Market Attractiveness Analysis, By Application                                       

                                5.3.8 Market Share Analysis, By Application                                        

                5.4 End User                                                      

                                5.4.1 Introduction                                           

                                5.4.2 Pharmaceutical And Biotechnology Companies                                      

                                5.4.3 Academic And Government Research Institutes                                    

                                5.4.4 Contract Research Organizations                                   

                                5.4.5 Other                                        

                                5.4.6 Y-o-Y Growth Analysis, By End User                                             

                                5.4.7  Market Attractiveness Analysis, By End User                                          

                                5.4.8  Market Share Analysis, By End User                                            

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Technology                   

                                                6.1.3.4 By Application                    

                                                6.1.3.5 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Technology                   

                                                6.1.4.4 By Application                    

                                                6.1.4.5 By End User                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Technology                   

                                                6.1.5.4 By Application                    

                                                6.1.5.5 By End User                        

                6.2 United States                                                            

                6.3 Canada                                                         

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Agilent Technologies Inc.                                                      

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Danaher Corporation                                                             

                8.3 Thermo Fisher Scientific Inc.                                                               

                8.4 PerkinElmer Inc.                                                       

                8.5 Tecan Group Ltd.                                                     

                8.6 Millipore                                                      

                8.7 Bio-Rad laboratories                                                               

                8.8 Hamilton Company                                                 

                8.9 Axxam S.p.A.                                                             

                8.10  Aurora Biomed.                                                     

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Application with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. North America High Throughput Screening Market, By Technology, From 2020 to 2025 (USD Million)
  2. North America Cell-based Assays Market, By Region, From 2020 to 2025 (USD Million)
  3. North America Lab-on-a-chip Market, By Region, From 2020 to 2025 (USD Million)
  4. North America Ultra-High-Throughput Screening Market, By Region, From 2020 to 2025 (USD Million)
  5. North America Label-Free Technology Market, By Region, From 2020 to 2025 (USD Million)
  6. North America Bioinformatics Market, By Region, From 2020 to 2025 (USD Million)
  7. North America High Throughput Screening Market, By Application, From 2020 to 2025 (USD Million)
  8. North America Target Identification Market, By Region, From 2020 to 2025 (USD Million)
  9. North America Primary Screening Market, By Region, From 2020 to 2025 (USD Million)
  10. North America Toxicology Market, By Region, From 2020 to 2025 (USD Million)
  11. North America Others Market, By Region, From 2020 to 2025 (USD Million)
  12. North America High Throughput Screening Market, By Product, From 2020 to 2025 (USD Million)
  13. North America Consumables and Reagents Market, By Region, From 2020 to 2025 (USD Million)
  14. North America Instruments Market, By Region, From 2020 to 2025 (USD Million)
  15. North America Software and Services Market, By Region, From 2020 to 2025 (USD Million)
  16. North America High Throughput Screening Market, By End User, From 2020 to 2025 (USD Million)
  17. North America Pharmaceutical and Biotechnology Companies Market, By Region, From 2020 to 2025 (USD Million)
  18. North America Academic and Government Research Institutes Market, By Region, From 2020 to 2025 (USD Million)
  19. North America Contract Research Organizations Market, By Region, From 2020 to 2025 (USD Million)
  20. North America Other End Users Market, By Region, From 2020 to 2025 (USD Million)
  21. United States High Throughput Screening Market, By Technology, From 2020 to 2025 (USD Million)
  22. United States High Throughput Screening Market, By Application, From 2020 to 2025 (USD Million)
  23. United States High Throughput Screening Market, By Product, From 2020 to 2025 (USD Million)
  24. United States High Throughput Screening Market, By End User, From 2020 to 2025 (USD Million)
  25. Canada High Throughput Screening Market, By Technology, From 2020 to 2025 (USD Million)
  26. Canada High Throughput Screening Market, By Application, From 2020 to 2025 (USD Million)
  27. Canada High Throughput Screening Market, By Product, From 2020 to 2025 (USD Million)
  28. Canada High Throughput Screening Market, By End User, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample